VRCA 241220 2.50C (VRCA241220C2500) Stock Options, News & Quotes

US OptionsDetailed Quotes

VRCA241220C2500

Watchlist

0.05
0.000.00%

15min DelayTrading Dec 10 10:07 ET

0.00High0.00Low

Intraday

5D
Daily

News

Verrica Pharmaceuticals Appoints New Chief Operating Officer
TipRanksDec 9 16:34 ET
Verrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswireDec 9 16:15 ET
Express News | Verrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
ReutersDec 9 16:15 ET
Verrica Pharmaceuticals' Partner Torii Seeks Japan Approval for Skin Infection Treatment
MT NewswiresDec 6 08:57 ET
Express News | Verrica Pharmaceuticals Announces That Development Partner Torii Pharmaceutical Files New Drug Application of to-208 the Treatment of Molluscum Contagiosum in Japan
ReutersDec 6 08:00 ET
Verrica Pharmaceuticals Announces That Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan
GlobeNewswireDec 6 08:00 ET

Comments

Jaguar8

Dec 6 07:00

NEWS

$Verrica Pharmaceuticals (VRCA.US)$
Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan
Friday, 6th December at 8:00 am
WEST CHESTER, Pa., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced its develop...

Bigmoney Dreamer

Nov 5 08:42

$Verrica Pharmaceuticals (VRCA.US)$ out no bag holding big percentage loser bad practice allowed to myself

Bigmoney Dreamer

Nov 5 07:45

$Verrica Pharmaceuticals (VRCA.US)$ 👀 dym -33% down i am out at open my technical analysis sucks not following my intelligent financial analyst advice broke own rule

Bigmoney Dreamer

Oct 29 16:57

$Verrica Pharmaceuticals (VRCA.US)$
Buying some in speculation and feeling some green days ahead due to presese of signal of uptrend and thinnner negetive free cash flow shrinkage year round no risk no substantial rewards looks like 5 year bottom rebounding

Teddy123

Oct 24 06:14

Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology C

$Verrica Pharmaceuticals (VRCA.US)$
WEST CHESTER, Pa., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the acceptanc...